Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Common Equity (2023 - 2025)

Vsee Health's Common Equity history spans 3 years, with the latest figure at $5.5 million for Q4 2025.

  • For Q4 2025, Common Equity rose 29591.39% year-over-year to $5.5 million; the TTM value through Dec 2025 reached $5.5 million, up 29591.39%, while the annual FY2025 figure was $5.5 million, 29591.39% up from the prior year.
  • Common Equity reached $5.5 million in Q4 2025 per VSEE's latest filing, up from -$5.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $5.5 million in Q4 2025 to a low of -$5.7 million in Q2 2025.
  • Average Common Equity over 3 years is -$1.9 million, with a median of -$1.8 million recorded in 2023.
  • The largest YoY upside for Common Equity was 29591.39% in 2025 against a maximum downside of 697.51% in 2025.
  • A 3-year view of Common Equity shows it stood at -$4.3 million in 2023, then skyrocketed by 99.57% to -$18488.0 in 2024, then soared by 29591.39% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for VSEE's Common Equity are $5.5 million (Q4 2025), -$5.6 million (Q3 2025), and -$5.7 million (Q2 2025).